Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women

Gail F. Shust; Jennifer Jao; Gabriela Rodriguez-Caprio; Roberto Posada; Katherine T. Chen; Amelia Averitt; Rhoda S. Sperling

doi:10.1093/jpids/pit019

Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women

Gail F. Shust^*, Jennifer Jao, Gabriela Rodriguez-Caprio, Roberto Posada, Katherine T. Chen, Amelia Averitt, Rhoda S. Sperling

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Combination antiretroviral therapy in pregnant women with human immunodeficiency virus has dramatically decreased maternal-to-child transmission. Highly treatment-experienced pregnant patients have limited effective treatment options due to past toxicities and viral resistance.We present 8 pregnancies in 7 perinatally infected women successfully treated with salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide.

Original language	English (US)
Pages (from-to)	246-250
Number of pages	5
Journal	Journal of the Pediatric Infectious Diseases Society
Volume	3
Issue number	3
DOIs	https://doi.org/10.1093/jpids/pit019
State	Published - Sep 1 2014

Keywords

Darunavir
Enfuvirtide
Etravirine
Pregnancy
Raltegravir

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jpids/pit019

Cite this

@article{8d82a593759945bf9bf3cf1ecee5f2b3,

title = "Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women",

abstract = "Combination antiretroviral therapy in pregnant women with human immunodeficiency virus has dramatically decreased maternal-to-child transmission. Highly treatment-experienced pregnant patients have limited effective treatment options due to past toxicities and viral resistance.We present 8 pregnancies in 7 perinatally infected women successfully treated with salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide.",

keywords = "Darunavir, Enfuvirtide, Etravirine, Pregnancy, Raltegravir",

author = "Shust, {Gail F.} and Jennifer Jao and Gabriela Rodriguez-Caprio and Roberto Posada and Chen, {Katherine T.} and Amelia Averitt and Sperling, {Rhoda S.}",

note = "Publisher Copyright: {\textcopyright} The Author 2013.",

year = "2014",

month = sep,

day = "1",

doi = "10.1093/jpids/pit019",

language = "English (US)",

volume = "3",

pages = "246--250",

journal = "Journal of the Pediatric Infectious Diseases Society",

issn = "2048-7207",

publisher = "Oxford University Press",

number = "3",

}

Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women. / Shust, Gail F.; Jao, Jennifer; Rodriguez-Caprio, Gabriela et al.

In: Journal of the Pediatric Infectious Diseases Society, Vol. 3, No. 3, 01.09.2014, p. 246-250.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women

AU - Shust, Gail F.

AU - Jao, Jennifer

AU - Rodriguez-Caprio, Gabriela

AU - Posada, Roberto

AU - Chen, Katherine T.

AU - Averitt, Amelia

AU - Sperling, Rhoda S.

N1 - Publisher Copyright: © The Author 2013.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Combination antiretroviral therapy in pregnant women with human immunodeficiency virus has dramatically decreased maternal-to-child transmission. Highly treatment-experienced pregnant patients have limited effective treatment options due to past toxicities and viral resistance.We present 8 pregnancies in 7 perinatally infected women successfully treated with salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide.

AB - Combination antiretroviral therapy in pregnant women with human immunodeficiency virus has dramatically decreased maternal-to-child transmission. Highly treatment-experienced pregnant patients have limited effective treatment options due to past toxicities and viral resistance.We present 8 pregnancies in 7 perinatally infected women successfully treated with salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide.

KW - Darunavir

KW - Enfuvirtide

KW - Etravirine

KW - Pregnancy

KW - Raltegravir

UR - http://www.scopus.com/inward/record.url?scp=84949122362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949122362&partnerID=8YFLogxK

U2 - 10.1093/jpids/pit019

DO - 10.1093/jpids/pit019

M3 - Article

C2 - 25844164

AN - SCOPUS:84949122362

VL - 3

SP - 246

EP - 250

JO - Journal of the Pediatric Infectious Diseases Society

JF - Journal of the Pediatric Infectious Diseases Society

SN - 2048-7207

IS - 3

ER -

Salvage regimens containing darunavir, etravirine, raltegravir, or enfuvirtide in highly treatment-experienced perinatally infected pregnant women

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this